ASCO/ESMO Breast Cancer Updates; Nurse vs. Hospital BoardDecember 09, 2020 | Oncology Internal Medicine ASCO Updates Guideline on Early Breast Cancer Treatment The American Society of Clinical Oncology (ASCO) published a guideline update about the selection of optimal adjuvant chemotherapy regimens and targeted therapy for early breast cancer, namely trastuzumab emtansine. In a second recommendation, the ASCO guideline addressed the use of biosimilar forms of trastuzumab—five of which have been approved by the FDA. Read full article Internal Medicine Highlights in Metastatic Breast Cancer From the European Society for Medical Oncology Virtual Congress 2020 This review and commentary from the ESMO Virtual Congress 2020 features a look at the following trials: ASCENT (sacituzumab govitecan-hziy), IMpassion130 (atezolizumab + nab-paclitaxel), IMpassion131 (first-line paclitaxel +/– atezolizumab), IPATunity130 (ipatasertib + paclitaxel), SEASTAR (rucaparib + sacituzumab govitecan), FLIPPER (fulvestrant/palbociclib), SOLAR-1 (alpelisib + fulvestrant), and FURVA (vandetanib + fulvestrant). Read full article Allergy & Immunology Fired Nurse Faces Board Review for Wearing Hospital Scrubs From MedPage Today comes this story about Cliff Willmeng, a registered nurse who was fired from United Hospital in St. Paul, MN, in May 2020. Willmeng believes the hospital board is investigating his conduct due to his standing up for his own safety and that of other nurses when he pressed for hospital scrubs over using and reusing his own, fearing he may bring the virus home. Read full article
DIET & NUTRITION 
PATIENT EDUCATION 
OBESITY/WEIGHT MANAGEMENT 
EXERCISE/TRAINING 
LEGAL MATTERS 
GUIDELINES/RECOMMENDATIONS